Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Risk Factors for Peri-Procedural Arterial Ischaemic Stroke in Children with Cardiac Disease.

Asakai H, Stojanovski B, Galati JC, Zannino D, Cardamone M, Hutchinson D, Cheung MMH, Mackay MT.

Pediatr Cardiol. 2017 Jul 11. doi: 10.1007/s00246-017-1674-x. [Epub ahead of print]

PMID:
28695245
2.

Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.

Saxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR.

Hepatology. 2017 May 15. doi: 10.1002/hep.29258. [Epub ahead of print]

PMID:
28504842
3.

Effect of gentamicin and levels of ambient sound on hearing screening outcomes in the neonatal intensive care unit: A pilot study.

Garinis AC, Liao S, Cross CP, Galati J, Middaugh JL, Mace JC, Wood AM, McEvoy L, Moneta L, Lubianski T, Coopersmith N, Vigo N, Hart C, Riddle A, Ettinger O, Nold C, Durham H, MacArthur C, McEvoy C, Steyger PS.

Int J Pediatr Otorhinolaryngol. 2017 Jun;97:42-50. doi: 10.1016/j.ijporl.2017.03.025. Epub 2017 Mar 21.

PMID:
28483249
4.

All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database.

Reddy KR, Lim JK, Kuo A, Di Bisceglie AM, Galati JS, Morelli G, Everson GT, Kwo PY, Brown RS Jr, Sulkowski MS, Akuschevich L, Lok AS, Pockros PJ, Vainorius M, Terrault NA, Nelson DR, Fried MW, Manns MP; HCV-TARGET Study Group.

Aliment Pharmacol Ther. 2017 Jan;45(1):115-126. doi: 10.1111/apt.13823. Epub 2016 Oct 28.

PMID:
27790729
5.

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.

Welzel TM, Nelson DR, Morelli G, Di Bisceglie A, Reddy RK, Kuo A, Lim JK, Darling J, Pockros P, Galati JS, Frazier LM, Alqahtani S, Sulkowski MS, Vainorius M, Akushevich L, Fried MW, Zeuzem S; HCV-TARGET Study Group.

Gut. 2016 Jul 13. pii: gutjnl-2016-311609. doi: 10.1136/gutjnl-2016-311609. [Epub ahead of print]

6.

Maternal iron status during pregnancy compared with neonatal iron status better predicts placental iron transporter expression in humans.

Best CM, Pressman EK, Cao C, Cooper E, Guillet R, Yost OL, Galati J, Kent TR, O'Brien KO.

FASEB J. 2016 Oct;30(10):3541-3550. Epub 2016 Jul 11.

PMID:
27402672
7.

No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.

Iyengar AJ, Winlaw DS, Galati JC, Wheaton GR, Gentles TL, Grigg LE, Justo RN, Radford DJ, Attard C, Weintraub RG, Bullock A, Sholler GS, Celermajer DS, d'Udekem Y; Australia and New Zealand Fontan Registry.

Eur J Cardiothorac Surg. 2016 Nov;50(5):980-987. Epub 2016 May 26.

PMID:
27229665
8.

Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.

Balogh J, Gordon Burroughs S, Boktour M, Patel S, Saharia A, Ochoa RA, McFadden R, Victor DW, Ankoma-Sey V, Galati J, Monsour HP Jr, Fainstein V, Li XC, Grimes KA, Gaber AO, Aloia T, Ghobrial RM.

Liver Transpl. 2016 Feb;22(2):163-70. doi: 10.1002/lt.24365. Epub 2016 Jan 8.

9.

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.

Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, Morelli G, Darling JM, Feld JJ, Brown RS, Frazier LM, Stewart TG, Fried MW, Nelson DR, Jacobson IM; HCV-TARGET Study Group.

Gastroenterology. 2016 Feb;150(2):419-29. doi: 10.1053/j.gastro.2015.10.013. Epub 2015 Oct 21.

10.

Arterial ischemic stroke in children with cardiac disease.

Asakai H, Cardamone M, Hutchinson D, Stojanovski B, Galati JC, Cheung MM, Mackay MT.

Neurology. 2015 Dec 8;85(23):2053-9. doi: 10.1212/WNL.0000000000002036. Epub 2015 Sep 25.

11.

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

Zeuzem S, Flisiak R, Vierling JM, Mazur W, Mazzella G, Thongsawat S, Abdurakhmanov D, Van Kính N, Calistru P, Heo J, Stanciu C, Gould M, Makara M, Hsu SJ, Buggisch P, Samuel D, Mutimer D, Nault B, Merz M, Bao W, Griffel LH, Brass C, Naoumov NV; ESSENTIAL II Study Group.

Aliment Pharmacol Ther. 2015 Oct;42(7):829-44. doi: 10.1111/apt.13342. Epub 2015 Aug 4.

12.

Association of in vitro fertilization with global and IGF2/H19 methylation variation in newborn twins.

Loke YJ, Galati JC, Saffery R, Craig JM.

J Dev Orig Health Dis. 2015 Apr;6(2):115-24. doi: 10.1017/S2040174415000161.

PMID:
25857739
13.

Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion.

Poh CL, Cochrane A, Galati JC, Bullock A, Celermajer DS, Gentles T, du Plessis K, Winlaw DS, Hornung T, Finucane K, d'Udekem Y.

Eur J Cardiothorac Surg. 2016 Feb;49(2):530-5; discussion 535. doi: 10.1093/ejcts/ezv112. Epub 2015 Apr 2.

PMID:
25838458
14.

Survival into adulthood of patients with atrial isomerism undergoing cardiac surgery.

Bhaskar J, Galati JC, Brooks P, Oppido G, Konstantinov IE, Brizard CP, d'Udekem Y.

J Thorac Cardiovasc Surg. 2015 Jun;149(6):1509-13. doi: 10.1016/j.jtcvs.2015.01.038. Epub 2015 Jan 24.

15.

Medium-term outcomes of bovine jugular vein graft and homograft conduits in children.

Yong MS, Yim D, d'Udekem Y, Brizard CP, Robertson T, Galati JC, Konstantinov IE.

ANZ J Surg. 2015 May;85(5):381-5. doi: 10.1111/ans.13018. Epub 2015 Feb 23.

PMID:
25708132
16.

New engineering treatment of bovine pericardium confers outstanding resistance to calcification in mitral and pulmonary implantations in a juvenile sheep model.

Brizard CP, Brink J, Horton SB, Edwards GA, Galati JC, Neethling WM.

J Thorac Cardiovasc Surg. 2014 Dec;148(6):3194-201. doi: 10.1016/j.jtcvs.2014.08.002. Epub 2014 Aug 7.

17.

Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand.

d'Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, Bullock A, Justo RN, Grigg LE, Sholler GF, Hope S, Radford DJ, Gentles TL, Celermajer DS, Winlaw DS.

Circulation. 2014 Sep 9;130(11 Suppl 1):S32-8. doi: 10.1161/CIRCULATIONAHA.113.007764.

18.

Repair of partial atrioventricular septal defect: a 37-year experience.

Buratto E, McCrossan B, Galati JC, Bullock A, Kelly A, d'Udekem Y, Brizard CP, Konstantinov IE.

Eur J Cardiothorac Surg. 2015 May;47(5):796-802. doi: 10.1093/ejcts/ezu286. Epub 2014 Aug 2.

PMID:
25086770
19.

End-to-side repair for aortic arch lesions offers excellent chances to reach adulthood without reoperation.

Lee MG, Brink J, Galati JC, Rakhra SS, Konstantinov IE, Cheung MM, Brizard CP, d'Udekem Y.

Ann Thorac Surg. 2014 Oct;98(4):1405-11. doi: 10.1016/j.athoracsur.2014.05.007. Epub 2014 Jul 17.

PMID:
25042678
20.

Impact of Blalock-Taussig shunt size on tricuspid regurgitation in hypoplastic left heart syndrome.

Asakai H, Galati JC, Weskamp S, Jones B, Millar J, Konstantinov IE, d'Udekem Y, Brizard CP, Cheung MM.

Ann Thorac Surg. 2014 Jun;97(6):2123-8. doi: 10.1016/j.athoracsur.2014.02.032. Epub 2014 Apr 14.

PMID:
24726597

Supplemental Content

Loading ...
Support Center